Page 149 - 南京医科大学学报自然科学版
P. 149
第42卷第6期 徐静纯,王 聪. H3K27me3在肿瘤中的研究进展[J].
2022年6月 南京医科大学学报(自然科学版),2022,42(06):897-902 ·901 ·
mediated down⁃regulation of E⁃cadherin[J]. J Cell Physi⁃ [21] FONTES⁃SOUSA M,LOBO J,LOBO S,et al. Digital im⁃
ol,2018,233(2):1359-1369 aging ⁃ assisted quantification of H3K27me3 immunoex⁃
[8] YI J Q,SHI X M,XUAN Z Y,et al. Histone demethylase pression in luminal A/B ⁃ like,HER2 ⁃ negative,invasive
UTX/KDM6A enhances tumor immune cell recruitment, breast cancer predicts patient survival and risk of recur⁃
promotes differentiation and suppresses medulloblastoma rence[J]. Mol Med,2020,26(1):22
[J]. Cancer Lett,2021,499:188-200 [22] HEALEY M A,HU R,BECK A H,et al. Association of
[9] SU I H,BASAVARAJ A,KRUTCHINSKY A N,et al. H3K9me3 and H3K27me3 repressive histone marks with
Ezh2 controls B cell development through histone H3 breast cancer subtypes in the nurses’health study[J].
methylation and Igh rearrangement[J]. Nat Immunol, Breast Cancer Res Treat,2014,147(3):639-651
2003,4(2):124-131 [23] HSIEH I Y,HE J C,WANG L,et al. H3K27me3 loss
[10] WEI Y K,XIA W Y,ZHANG Z H,et al. Loss of trimethy⁃ plays a vital role in CEMIP mediated carcinogenesis and
lation at lysine 27 of histone H3 is a predictor of poor out⁃ progression of breast cancer with poor prognosis[J].
come in breast,ovarian,and pancreatic cancers[J]. Mol Biomed Pharmacother,2020,123:109728
Carcinog,2008,47(9):701-706 [24] DU T H,WANG D,WAN X Y,et al. Regulatory effect of
[11] BERNARDES N E,CHOOK Y M. Nuclear import of his⁃ microRNA⁃223⁃3p on breast cancer cell processes via the
tones[J]. Biochem Soc Trans,2020,48(6):2753-2767 Hippo/Yap signaling pathway[J]. Oncol Lett,2021,22
[12] ASATOOR A M. The occurrence of Epsilon⁃N⁃methylly⁃ (1):516
sine in human urine[J]. Clin Chim Acta,1969,26(1): [25] MA L,SHAN L. ACTL6A promotes the growth in non ⁃
147-154 small cell lung cancer by regulating Hippo/Yap pathway
[13] KIM S,PAIK W K. Studies on the origin of Epsilon⁃N⁃ [J]. Exp Lung Res,2021,47(5):250-259
methyl⁃L⁃lysine in protein[J]. J Biol Chem,1965,240 [26] LIU X,LI C,ZHANG R D,et al. The EZH2⁃ H3K27me3⁃
(12):4629⁃4634 DNMT1 complex orchestrates epigenetic silencing of the
[14] ZHANG J,JING L,LI M H,et al. Regulation of histone ar⁃ wwc1 gene,a Hippo/YAP pathway upstream effector,in
ginine methylation/demethylation by methylase and de⁃ breast cancer epithelial cells[J]. Cell Signal,2018,51:
methylase(review)[J]. Mol Med Rep,2019,19(5): 243-256
3963-3971 [27] SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer sta⁃
[15] WANG Z Z,CAI H R,ZHAO E H,et al. The diverse roles tistics 2020:GLOBOCAN estimates of incidence and mor⁃
of histone demethylase KDM4B in normal and cancer de⁃ tality worldwide for 36 cancers in 185 countries[J]. CA
velopment and progression[J]. Front Cell Dev Biol,2022, Cancer J Clin,2021,71(3):209-249
9:790129 [28] HE W P,LI Q,ZHOU J,et al. Decreased expression of
[16] VAN WIJNEN A J,BAGHERI L,BADRELDIN A A,et al. H3K27me3 in human ovarian carcinomas correlates with
Biological functions of chromobox(CBX)proteins in stem more aggressive tumor behavior and poor patient survival
cell self⁃renewal,lineage⁃commitment,cancer and deve⁃ [J]. Neoplasma,2015,62(6):932-937
lopment[J]. Bone,2021,143:115659 [29] LIU T,CAI J,CAI J,et al. EZH2⁃miRNA positive feed⁃
[17] INOUE A,JIANG L,LU F L,et al. Maternal H3K27me3 back promotes tumor growth in ovarian cancer[J]. Front
controls DNA methylation ⁃ independent imprinting[J]. Oncol,2021,10:608393
Nature,2017,547(7664):419-424 [30] CAI C Y,PENG X,ZHANG Y M. Downregulation of cell
[18] LIU F,GU L,CAO Y,et al. Aberrant overexpression of division cycle ⁃ associated protein 7(CDCA7)suppresses
EZH2 and H3K27me3 serves as poor prognostic biomark⁃ cell proliferation,arrests cell cycle of ovarian cancer,and
er for esophageal squamous cell carcinoma patients[J]. restrains angiogenesis by modulating enhancer of zeste ho⁃
Biomarkers,2016,21(1):80-90 molog 2(EZH2)expression[J]. Bioengineered,2021,12
[19] LIN S F,ZHOU M H,LI Y P,et al. H3K27 trimethylation (1):7007-7019
and H3K9 dimethylation as poor prognostic markers for [31] LIN L,WANG Z W,JIN H H,et al. miR⁃212/132 is epi⁃
patients with esophageal squamous cell carcinoma[J]. Int genetically downregulated by SOX4/EZH2 ⁃ H3K27me3
J Clin Exp Pathol,2019,12(7):2657-2664 feedback loop in ovarian cancer cells[J/OL]. Tumour Bi⁃
[20] CHRUN E S,MODOLO F,DANIEL F I. Histone modifica⁃ ol,2016,2016. doi:10.1007/S13277⁃016⁃5339⁃9
tions:a review about the presence of this epigenetic phe⁃ [32] SUN S,YANG Q,CAI E,et al. EZH2/H3K27Me3 and
nomenon in carcinogenesis[J]. Pathol Res Pract,2017, phosphorylated EZH2 predict chemotherapy response and
213(11):1329-1339 prognosis in ovarian cancer[J]. PeerJ,2020,8:e9052